Bioorganic and Medicinal Chemistry Letters p. 4285 - 4288 (2003)
Update date:2022-08-04
Topics:
Perkins, James J.
Duong
Fernandez-Metzler, Carmen
Hartman, George D.
Kimmel, Donald B.
Leu, Chih-Tai
Lynch, Joseph J.
Prueksaritanont, Thomayant
Rodan, Gideon A.
Rodan, Sevgi B.
Duggan, Mark E.
Meissner, Robert S.
Antagonists of the integrin receptor αvβ3 are expected to have utility in the treatment of osteoporosis through inhibition of bone resorption. A series of potent, chain-shortened, pyrrolidinone-containing αvβ3 receptor antagonists is described. Two sets of diasteromeric pairs of high-affinity antagonists demonstrated marked differences in log P values, which translated into differing dog pharmacokinetic properties. One member of this set was demonstrated to be effective in reducing bone resorption in rats.
View MoreTianjin Dongchang Fine Chemical Industry Co., Ltd.
Contact:+86-22-29894595
Address:Economic Developing Zone, Ji County, Tianjin, China
Nanjing Chemical Material Corp.(NCMC)
website:http://www.njchemm.com
Contact:0086-25-83172879
Address:B12 Technology and Innovation Building, Nanjing Tech University, No.5 New Model Road
Contact:+86-519-86623222
Address:29F/D, 99 Yanling West Road, Changzhou, Jiangsu, China
Qingdao XinYongAn Chemicals Co., Ltd
Contact:+86-532-81107967
Address:Chengyang dual-port industrial park by the sea,Qingdao
Contact:86-512-87182055
Address:No.128 Fangzhou Rd, Suzhou Industrial Park, China, 215125, China
Doi:10.1021/ja01860a014
(1940)Doi:10.1016/S0040-4039(99)00577-8
(1999)Doi:10.1016/S0968-0896(02)00606-5
(2003)Doi:10.1039/j39690001346
(1969)Doi:10.1016/S0040-4020(99)00307-5
(1999)Doi:10.1016/S0031-9422(00)91376-1
(1974)